Search for: "Vivus, Inc."
Results 1 - 13
of 13
Sorted by Relevance
|
Sort by Date
15 Nov 2015, 9:32 pm
Vivus, Inc. v. [read post]
29 Feb 2012, 9:07 am
Details on Qnexa Qnexa is a weight-loss drug manufactured by Vivus Inc. [read post]
20 Jul 2012, 12:25 pm
The drug is made by Vivus Inc. and it’s called Qsymia, formerly known as Qnexa. [read post]
5 Apr 2011, 4:24 pm
Qnexa is manufactured by the drug company Vivus Inc., based in Mountain View, California. [read post]
11 Aug 2010, 4:41 am
An FDA committee will review the safety risk of weight-loss drug Meridia the day before evaluating Arena Pharmaceuticals Inc.'s drug for treating obesity. [read post]
1 Jul 2012, 6:07 pm
Vivus Inc. and Orexigen Therapeutics Inc. are reportedly also trying to get their own versions of diet pills approved. [read post]
1 Jul 2012, 6:07 pm
Vivus Inc. and Orexigen Therapeutics Inc. are reportedly also trying to get their own versions of diet pills approved. [read post]
1 Feb 2011, 2:00 pm
Request For Historical Incidence Data Made In Connection With NDA For New Obesity Drug (Posted by Tom Lamb at DrugInjuryWatch.com)In mid-January 2011 the biopharmaceutical company Vivus, Inc. -- while providing a regulatory update on its New Drug Application (NDA) for QNEXA -- announced that the FDA had asked the company to look into the possibility that the drug Topamax (topiramate) is associated with a certain type of birth defect, oral cleft. [read post]
1 Mar 2012, 3:16 am
In October 2010, when Qnexa was first submitted by the manufacturer, Vivus Inc., the FDA rejected the diet pill due to concerns over side effects such as raised heart rate, psychiatric problems and birth defects. [read post]
5 Aug 2016, 2:10 pm
Current Product Liability Litigation Cases Which Involve Popular Drugs With Serious Side Effects That Are Starting To Gain More Attention (Posted by Tom Lamb at DrugInjuryWatch.com) This article will feature three types of drug injury cases that are starting to gain some momentum in terms of the number of lawsuits filed against the responsible pharmaceutical companies in courts across the country. (1) Diabetes Medicines in the Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors Class of… [read post]
1 May 2012, 10:00 am
-based VIVUS Inc. [read post]
6 Jun 2012, 4:34 pm
Lorcaserin by Arena Qnexa by Vivus Inc. [read post]
19 Jul 2022, 2:59 pm
BioMimetic Therapeutics, Inc., 2013 WL 139521, at *13-14 (M.D. [read post]
